99 Publications (Page 2 of 4)
2013
Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis.
Cao, HuilingZhu, KeQiu, LuguiLi, ShuaiNiu, HanjieHao, MuYang, ShengyongZhao, ZhongfangLai, YumeiAnderson, Judith LFan, JieIm, Hee-JeongChen, DiRoodman, G David and Xiao, Guozhi
The Journal of biological chemistry, vol. 288, (no. 42), pp. 30399-30410, October 18, 2013. | Journal Article
 
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.
Storti, PBolzoni, MDonofrio, GAiroldi, IGuasco, DToscani, DMartella, ELazzaretti, MMancini, CAgnelli, LPatrene, KMaïga, SFranceschi, VColla, SAnderson, JNeri, AAmiot, MAversa, FRoodman, G David and Giuliani, N
Leukemia, vol. 27, (no. 8), pp. 1697-1706, August 2013. | Journal Article
 
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Terpos, EvangelosMorgan, GarethDimopoulos, Meletios-IoannisDrake, Matthew TLentzsch, SuzanneRaje, NoopurSezer, OrhanGarcía-Sanz, RamónShimizu, KazuyukiTuresson, IngemarReiman, Anthony JJurczyszyn, ArturMerlini, GiampaoloSpencer, AndrewLeleu, XavierCavo, MicheleMunshi, Nikhil CRajkumar, S. VDurie, Brian G and Roodman, G D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 18), pp. 2347-57, 2013/Jun/20. | Journal Article
 
Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling
Wang, Feng-MingSarmasik, AliyeHiruma, YukoSun, QuanhongSammut, BenedicteWindle, Jolene JRoodman, GDavid and Galson, Deborah L
Bone, vol. 53, (no. 1), pp. 269-276, 2013. | Journal Article
 
Optimal use of bisphosphonates in patients with multiple myeloma.
Terpos, EvangelosRoodman, G David and Dimopoulos, Meletios A
Blood, vol. 121, (no. 17), pp. 3325-3328, April 25, 2013. | Journal Article
 
Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi, JumpeiHiruma, YukoIshizuka, SeiichiIshizuka, HisakoBrown, Jacques PMichou, LaëtitiaCao, HuilingGalson, Deborah LSubler, Mark AZhou, HuaDempster, David WWindle, Jolene JRoodman, Garson D and Kurihara, Noriyoshi
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 28, (no. 6), pp. 1489-500, 2013/Jun. | Journal Article
2012
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.
D'Souza, SoniaD'Souza, SoniaD’Souza, S.Kurihara, NoriyoshiKurihara, NoriyoshiShiozawa, YusukeShiozawa, YusukeJoseph, JeenaJoseph, JeenaTaichman, RussellTaichman, RussellGalson, Deborah LGalson, Deborah LRoodman, G D and Roodman, G David
Blood, vol. 119, (no. 8), pp. 1888-96, 2012/Feb/23. | Journal Article
 
Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.
Xu, GuoshuangLiu, KaiAnderson, JudyPatrene, KennethLentzsch, SuzanneRoodman, G David and Ouyang, Hongjiao
Blood, vol. 119, (no. 18), pp. 4205-4214, May 3, 2012. | Journal Article
 
Genes associate with abnormal bone cell activity in bone metastasis.
Roodman, Garson D
Cancer metastasis reviews, vol. 31, (no. 3-4), pp. 569-78, 2012/Dec. | Journal Article
 
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors.
Yang, PengMyint, Kyaw-ZeyarTong, QinFeng, RentianCao, HaipingAlmehizia, Abdulrahman AAlqarni, Mohammed HWang, Li RongBartlow, PatrickGao, YingdaiGertsch, JürgTeramachi, JumpeiKurihara, NoriyoshiRoodman, Garson DCheng, Tao and Xie, Xiang Qun S
Journal of medicinal chemistry, vol. 55, (no. 22), pp. 9973-87, 2012/Nov/26. | Journal Article
2011
Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche.
Jung, YounghunShiozawa, YusukeWang, JingchengPatel, Lalit RHavens, Aaron MSong, JunhuiKrebsbach, Paul HRoodman, G D and Taichman, Russell S
Experimental hematology, vol. 39, (no. 2), pp. 151-166.e1, 2011/Feb. | Journal Article
 
Bone effects of cancer therapies: pros and cons.
Silbermann, Rebecca and Roodman, G David
Current opinion in supportive and palliative care, vol. 5, (no. 3), pp. 251-257, September 2011. | Journal Article
 
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.
Holkova, BeataPerkins, E BRamakrishnan, ViswanathanTombes, Mary BShrader, EllenTalreja, NehaWellons, Martha DHogan, Kevin TRoodman, G DCoppola, DomenicoKang, LoveleenDawson, JanaStuart, Robert KPeer, CodyFigg, William DKolla, SarahDoyle, AustinWright, JohnSullivan, Daniel MRoberts, John D and Grant, Steven
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 17, (no. 10), pp. 3388-97, 2011/May/15. | Journal Article
 
Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells.
Wang, Feng-MingGalson, Deborah LRoodman, G D and Ouyang, Hongjiao
Experimental hematology, vol. 39, (no. 10), pp. 999-1006, 2011/Oct. | Journal Article
2010
Activating transcription factor 4 regulates osteoclast differentiation in mice.
Cao, HuilingCao, HuilingYu, ShibingYu, ShibingYao, ZhiYao, ZhiGalson, Deborah LGalson, Deborah LJiang, YuJiang, YuZhang, XiaoyanZhang, XiaoyanFan, JieFan, JieLu, BinfengLu, BinfengGuan, YoufeiGuan, YoufeiLuo, MinLuo, MinLai, YumeiLai, YumeiZhu, YibeiZhu, YibeiKurihara, NoriyoshiKurihara, NoriyoshiPatrene, KennethPatrene, KennethRoodman, G. DRoodman, G DavidXiao, Guozhi and Xiao, Guozhi
The Journal of clinical investigation, vol. 120, (no. 8), pp. 2755-66, 2010/Aug. | Journal Article
 
Insights into the pathogenesis of Paget's disease
Roodman, G. D
Annals of the New York Academy of Sciences, vol. 1192, (no. 1), pp. 176-180, 2010. | Journal Article
 
Metastasis and bone loss: advancing treatment and prevention.
Coleman, R.E.Coleman, Robert ELipton, A.Lipton, AllanRoodman, G DRoodman, G.D.Guise, T.A.Guise, Theresa ABoyce, B.F.Boyce, Brendon FBrufsky, Adam MBrufsky, A.M.Clézardin, P.Clézardin, PhilippeCroucher, Peter ICroucher, P.I.Gralow, J.R.Gralow, Julie RHadji, PeymanHadji, P.Holen, I.Holen, IngunnMundy, Gregory RMundy, G.R.Smith, Matthew RSmith, M.R.Suva, L.J. and Suva, Larry J
Cancer treatment reviews, vol. 36, (no. 8), pp. 615-20, 2010/Dec. | Journal Article
 
Osteoclasts are important for bone angiogenesis.
Cackowski, Frank CAnderson, Judith LPatrene, Kenneth DChoksi, Rushir JShapiro, Steven DWindle, Jolene JBlair, Harry C and Roodman, G D
Blood, vol. 115, (no. 1), pp. 140-9, 2010/Jan/7. | Journal Article
 
Targeting the bone microenvironment in multiple myeloma
Roodman, G. D
Journal of bone and mineral metabolism JBMM., vol. 28, (no. 3), pp. 244-250, 2010. | Journal Article
2009
Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone
Yu, ShibingFranceschi, RennyLuo, MinFan, JieJiang, DiCao, HuilingKwon, Tae-GeonLai, YumeiZhang, JianPatrene, KennethHankenson, KurtRoodman, GDavidXiao, Guozhi and Bartell, Paul A
PLoS ONE, vol. 4, (no. 10), pp. e7583, 2009. | Journal Article
 
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.
Hiruma, YukoHiruma, YukoHonjo, TadashiHonjo, TadashiJelinek, Diane FJelinek, Diane FWindle, Jolene JWindle, Jolene JShin, JaekyoonShin, JaekyoonRoodman, G DavidRoodman, G DKurihara, Noriyoshi and Kurihara, Noriyoshi
Blood, vol. 113, (no. 20), pp. 4894-902, 2009/May/14. | Journal Article
 
Osteoclasts pump iron.
Roodman, G David
Cell metabolism, vol. 9, (no. 5), pp. 405-406, May 2009. | Journal Article
 
The role of bisphosphonates in multiple myeloma.
Levy, Jessica and Roodman, G David
Current hematologic malignancy reports, vol. 4, (no. 2), pp. 108-112, April 2009. | Journal Article
 
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors.
Lipton, AllanUzzo, RobertAmato, Robert JEllis, Georgiana KHakimian, BehroozRoodman, G David and Smith, Matthew R
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 7 Suppl 7, pp. S1-29; quiz S30, October 2009. | Journal Article
2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
Coleman, Robert EColeman, R.E.Guise, Theresa AGuise, T.A.Lipton, A.Lipton, AllanRoodman, G DRoodman, G.D.Berenson, James RBerenson, J.R.Body, J.-J.Body, Jean-JacquesBoyce, B.F.Boyce, Brendan FCalvi, Laura MCalvi, L.M.Hadji, P.Hadji, PeymanMcCloskey, Eugene VMcCloskey, E.V.Saad, FredSaad, F.Smith, M.R.Smith, Matthew RSuva, L.J.Suva, Larry JTaichman, R.S.Taichman, Russell SVessella, R.L.Vessella, Robert LWeilbaecher, K.N. and Weilbaecher, Katherine N
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 14, (no. 20), pp. 6387-95, 2008/Oct/15. | Journal Article